20349 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole; Thiazoles condensed with heterocyclic ring systems
Ternary Pesticidal Mixtures
#302Therapeutic compounds for blocking DNA synthesis of pox viruses
#303Method for preparing largazole analogs and uses thereof
#304Pesticidal mixtures
#305COMPOUNDS EXHIBITING THROMBOPOIETIN RECEPTOR AGONISM
#306COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASE CAUSED BY YERSINIA SPP INFECTION
#307DIAMINE DERIVATIVES
#308Combination of at least two 5HT6-Ligands
#309METHODS FOR IDENTIFYING NUCLEAR RECEPTOR/LIGAND COMBINATIONS FOR TARGETING BRAIN TUMOR STEM CELLS AND FOR THEIR USE
#310Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
#311Methods for the treatment of muscle loss
#312Compounds as cannabinoid receptor ligands
#313TARGETED BONE MARROW PROTECTION AGENTS
#314METHOD FOR TREATING ADAMTS-5-ASSOCIATED DISEASE
#315BONE TARGETING OF DEGRADABLE DRUG FILLED NANOPARTICLES
#316Compounds as cannabinoid receptor ligands
#317(1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
#318Imidazole and Thioazole Derivatives as Antiviral Agents
#319Pharmaceutically Active Tetrahydro-Pyrrolo[1,2-B]Isothiazole 1,1-Dioxides
#320Cxcr4 Binding Molecules
#321p53 Inhibitors and Therapeutic Use of the Same
#322METHODS FOR TREATING DELAYING THE PROGRESSION OF ALZHEIMER'S DISEASE WITH HETEROCYCLIC COMPOUNDS
#323METHODS FOR TREATING DEPRESSION, NEURODEGENERATION, INHIBITING AMYLOID BETA DEPOSITION, DELAYING SENESCENCE, AND EXTENDING LIFE SPANS WITH HETEROCYCLIC COMPOUNDS
#324Trace elements
#325Compounds as cannabinoid receptor ligands and uses thereof
#326Benzothniazole compositions and their use as ubiquition ligation inhibitors
#327DIAMINE DERIVATIVES
#328Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer
#329Imidazolothiazole compounds for the treatment of disease
#330Biaryl sulfonamides and methods for using same
#331Bicyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic
#332Blood flow promoters for cauda equina tissues
#3331-Thia-3-aza-dibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders
#334Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity
#335Compounds exhibiting thrombopoietin receptor agonism
#336Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors
#337Guanidine derivatives and their use as neuropeptide FF receptor antagonists
#338GM-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent
#339Use of 5-HT6 agonist for the treatment and prevention of neurodegenerative disorders
#340Levamisole, avermectins or similar in pyrrolidone solvent
#341Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity
#342Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#343Method for treating ADAMTS-5-associated disease
#344Topical use of bis-arylimidazo[1,2-a]thiolane derivatives
#345Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
#346Nitrogen-containing compounds
#347Diamine derivatives
#348p53 Inhibitors and therapeutic use of the same
#349Combinations for the treatment of proliferative diseases
#350Aminomethyl-substituted thiazolobenzimidazole compounds
#351Benzothiazole compositions and their use as ubiquitin ligase inhibitors
#352Biaryl sulfonamides and methods for using same
#353Diamine derivatives
#354Organosulfur inhibitors of tyrosine phosphatases
#355Diamine derivatives
#356Nanoformulation of spriooxindole and methods for treating hepatocellular carcinoma